Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)
Titel:
Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)
Auteur:
Vamvakas, L. Karampeazis, A. Agelaki, S. Kentepozidis, N. Polyzos, A. Kotsakis, A. Kalbakis, K. Christofyllakis, C. Kontopodis, E. Pallis, A.G. Georgoulias, V.